Haemonetics Company Profile

19:03 EDT 24th September 2018 | BioPortfolio

For more than 30 years, Haemonetics has been a global leader in blood processing technology. The Company has two families of products:
Donor Products - These products are marketed to the blood donation industry and include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit.

Patient Products - These products are marketed to the surgical suite for blood loss management for patients. The products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.


400 Wood Rd
United States of America


Phone: (800) 225-5242

News Articles [9 Associated News Articles listed on BioPortfolio]

$700M debt refinancing finalized by Haemonetics

Braintree, Mass.-based Haemonetics has announced the completion of debt refinancing through which it secured a $700 million c -More- 

Opko Health (OPK) and Haemonetics (HAE) Financial Survey

Opko Health and Haemonetics are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings,...

Acrodose PLus and PL Systems by Haemonetics: Recall - Low pH Readings for Platelets Stored in CLX HP Bag

Audience: Laboratory [Posted 04/13/2018] ISSUE: Haemonetics recently received reports of low pH readings for platelets stored in the CLX HP bag in certain lots of the Acrodose PLus and PL systems. In...

Haemonetics enters $700mm loan agreement

Haemonetics Corp. (blood management devices and services) entered into a $700mm loan agreement, which includes a $350mm unsecured term loan and a $350mm senior unsecured revolving credit facility. Bot...

Haemonetics Continues To Be A Buy Story In 2018

It Is Still Not Too Late To Pick Up Haemonetics In CY 2018

Haemonetics (HAE) Q4 2018 Results - Earnings Call Transcript

Haemonetics Corp's (HAE) CEO Christopher Simon on Q1 2019 Results - Earnings Call Transcript

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder

This study evaluates whether whole blood transferred through the new POLFA needle assembly meets supernatant hemoglobin acceptability standards.

The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass

This study evaluates the enhanced recovery after surgery (ERAS) concept over conventional postoperative care in patients with heart valve disease undergoing cardiac surgery with cardiopulm...

Companies [0 Results]


More Information about "Haemonetics" on BioPortfolio

We have published hundreds of Haemonetics news stories on BioPortfolio along with dozens of Haemonetics Clinical Trials and PubMed Articles about Haemonetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Haemonetics Companies in our database. You can also find out about relevant Haemonetics Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record